Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Fluorouracil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 15 USDMF, 4 CEP/COS, 2 JDMF, 12 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

200 Drugs in Development

200 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

208 FDF Dossiers, 70 FDA Orange Book, 86 Europe, 7 Canada, 20 Australia, 11 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%, SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.5%, CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 Kirsch Pharma, 5 Actylis, 1 Ashland, 10 BASF, 1 BioSpectra, 1 CD Formulation, 1 Clariant, 2 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 6 Gangwal Chemicals, 2 Gloria Interchem, 1 Kerry, 2 Lubrizol Life Science Health, 3 Microlex e.U, 2 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 9 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical, 21 Solubilizers, 17 Parenteral, 14 Thickeners and Stabilizers, 12 Emulsifying Agents, 11 Film Formers & Plasticizers, 8 Surfactant & Foaming Agents, 8 Coating Systems & Additives, 4 Direct Compression, 4 Lubricants & Glidants, 4 Fillers, Diluents & Binders, 2 Granulation, 2 Controlled & Modified Release, 2 Rheology Modifiers, 1 Co-Processed Excipients, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 53 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

16 APIs, 15 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 1 USP, 16 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

CREAM;TOPICAL - 5%

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Fluorouracil

Fluorouracil

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

15 USDMF

4 CEP/COS

2 JDMF

12 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

200 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

208 FDF Dossiers

70 FDA Orange Book

86 Europe

7 Canada

20 Australia

11 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;TOPICAL - 2%

SOLUTION;TOPICAL - 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.5%

CREAM;TOPICAL - 4%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 Kirsch Pharma

5 Actylis

1 Ashland

10 BASF

1 BioSpectra

1 CD Formulation

1 Clariant

2 Corel Pharma Chem

1 Esteem Industries

2 Finar

6 Gangwal Chemicals

2 Gloria Interchem

1 Kerry

2 Lubrizol Life Science Health

3 Microlex e.U

2 Nanjing Bold Chemical

1 Pluviaendo

4 Roquette

9 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Topical

21 Solubilizers

17 Parenteral

14 Thickeners and Stabilizers

12 Emulsifying Agents

11 Film Formers & Plasticizers

8 Surfactant & Foaming Agents

8 Coating Systems & Additives

4 Direct Compression

4 Lubricants & Glidants

4 Fillers, Diluents & Binders

2 Granulation

2 Controlled & Modified Release

2 Rheology Modifiers

1 Co-Processed Excipients

1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

53 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions

12 Regulatory FDF Prices

1 Annual Reports

MARKET PLACE

SOLUTION;TOPICAL - 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons